Palaniappan Kulanthaivel

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

Amita Patnaik, Lee S. Rosen, Sara M. Tolaney et al. · Cancer Discovery · 2016 · 760 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft

Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel et al. · Drug Metabolism and Disposition · 2015 · 281 citations

Medicine, Oncology, Pharmacology +17

Balanol: a novel and potent inhibitor of protein kinase C from the fungus Verticillium balanoides

Palaniappan Kulanthaivel, Yali F. Hallock, Christie Boros et al. · Journal of the American Chemical Society · 1993 · 213 citations

Life Sciences, Biochemistry, Pharmacology +8

SELECTIVE METABOLISM OF VINCRISTINE IN VITRO BY CYP3A5

Jennifer B. Dennison, Palaniappan Kulanthaivel, Robert J. Barbuch et al. · Drug Metabolism and Disposition · 2006 · 171 citations

Medicine, Pharmacokinetics, Pharmacology +17

A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds

Andrew M. Sawayama, Michael M. Y. Chen, Palaniappan Kulanthaivel et al. · Chemistry - A European Journal · 2009 · 146 citations · Full text

Medicine, Pharmacology, Toxicology +15